Comparison of the Prophylactic Effect Between Acupuncture and Acupressure on Menstrual Migraine
1 other identifier
interventional
120
0 countries
N/A
Brief Summary
This study is designed to make comparisons between acupuncture and acupressure for preventing menstrual migraine (MM). Whether acupuncture is superior to acupressure is the most interesting point of this study. First of all, females will be screened for eligibility. Then, all participants who meet the inclusion criteria will be asked to keep a headache migraine diary for three months as baseline data. The diaries will then be collected before the first treatment. Then, all the participants will receive the corresponding interventions on the eighth, fifth and second days before the estimated first day of menstruation (determined individually from the diaries) in each month for three months (menstrual cycle), making a total of nine treatment sessions. After the whole treatments, there will be a three-month follow-up period. All the participants will be asked to complete the headache diaries every month from baseline to the end of the study. The diaries recording data from the fourth to the ninth month will then be collected at the end of the ninth month for the second time indicating the end of the study for the participants. In case of an acute migraine attack, participants will not be restricted from using "normal" medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2015
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2015
CompletedFirst Posted
Study publicly available on registry
October 30, 2015
CompletedStudy Start
First participant enrolled
November 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedOctober 30, 2015
October 1, 2015
9 months
October 27, 2015
October 28, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change from baseline menstrual migraine attack frequency at 9 months
Once the patient is free of headache for 48 hours, a new attack will be considered another headache.
from the date of admission into this study to the date of completion of this study, assessed up to 9 months
Secondary Outcomes (5)
change from baseline number of migraine days at 9 months
from the date of admission into this study to the date of completion of this study, assessed up to 9 months
change from baseline average visual analogue scale (VAS) at 9 months
from the date of admission into this study to the date of completion of this study, assessed up to 9 months
change from baseline total duration period of pain (hours) at 9 months
from the date of admission into this study to the date of completion of this study, assessed up to 9 months
change from baseline number of days with analgesic medication at 9 months
per month, from the date of admission into this study to the date of completion of this study, assessed up to 9 months
change from baseline the absence from work days or school days and/or classes missed at 9 months
from the date of admission into this study to the date of completion of this study, assessed up to 9 months
Study Arms (3)
verum acupuncture
EXPERIMENTALParticipants will receive real needle insertion. The needles will be left in the acupoint for 20 min, with a manual rotation at a ten-min interval. Primary acupoints used in the verum acupuncture group will be: LR3 (Taichong), LI4 (Hegu), SP6 (Sanyinjiao), GB20 (Fengchi). Extra acupoints will be selected based on TCM pattern are GB41 (Zulinqi), SP10 (Xuehai), KI3 (Taixi), or LR2 (Xingjian).
acupressure
ACTIVE COMPARATORAcupressure will be applied on all the corresponding acupoints described in the acupuncture group. Duration of each session will be 15 min.
control acupuncture
SHAM COMPARATORThe number, duration, and frequency of the sessions will be the same as for the verum acupuncture group. The points chosen will be: LR7 (Xiguan), GB35 (Yangjiao), LI12 (Zhouliao), M-BW-1 (Dingchuan).
Interventions
Participants will receive real needle insertion. Sterile needles will be used on all acupoints. The depth of insertion will vary from 15 mm to 20 mm depending on the exact locations. An initial manual stimulation will be given at insertion by rotation methods to produce a specific sensation described as "de-qi" in TCM. Then the needles will be left in the acupoint for 20 min, with a manual rotation at 4-8 Hz and an amplitude of approximately 0.5-2 rotations at a ten-min interval to maintain the sensation of "de-qi". Primary acupoints used in the verum acupuncture group will be: LR3 (Taichong), LI4 (Hegu), SP6 (Sanyinjiao), GB20 (Fengchi). Extra acupoints will be selected based on TCM pattern are GB41 (Zulinqi), SP10 (Xuehai), KI3 (Taixi), or LR2 (Xingjian).
The acupoints and the number of the sessions will be exactly the same as for the verum acupuncture group. Acupressure will be applied on all the corresponding acupoints described in the acupuncture group. Finger pressure will be applied to each acupoint for eight seconds followed by two-seconds rest, repeated for 3 min. The strength of the pressure depends on individual participant's sensation of "de-qi". Duration of each session will be 15 min.
The number, duration, and frequency of the sessions will be the same as for the verum acupuncture group. Sterile needles will be used on acupoints that have no therapeutic effect on either menstruation or migraines, based on the acupuncture text books and acupuncture research literature. The points chosen will be: LR7 (Xiguan), GB35 (Yangjiao), LI12 (Zhouliao), M-BW-1 (Dingchuan). The depth of needle insertion will be as superficial as 3 mm, and without manual rotation, in order to minimize stimulation of the needle.
Eligibility Criteria
You may qualify if:
- females aged from 18 to 40;
- a diagnosis of pure menstrual migraine or menstrually related migraine according to the criteria of the International Classification of Headache Disorders III beta version;
- regular menstrual periods;
- repeated self-considered MM attacks of at least half a year;
- no plan to become pregnant or change hormonal treatment during the study; and
- voluntarily joining this study and providing informed consent.
You may not qualify if:
- difficulties in differentiating migraine from other types of headaches;
- other primary headaches such as tension-type headache and cluster headache, and secondary headache;
- lack of time and/or motivation to participate;
- starting in use of any new kind of migraine prophylactic drugs in the last three months;
- serious cardiovascular, neurological, or psychiatric diseases according to self-reported medical history;
- severe bleeding disorder or anticoagulation according to the medical history;
- a cardiac pacemaker;
- metal allergy;
- a severe needle phobia;
- or if they are pregnant or lactating.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (12)
Alecrim-Andrade J, Maciel-Junior JA, Carne X, Severino Vasconcelos GM, Correa-Filho HR. Acupuncture in migraine prevention: a randomized sham controlled study with 6-months posttreatment follow-up. Clin J Pain. 2008 Feb;24(2):98-105. doi: 10.1097/AJP.0b013e3181590d66.
PMID: 18209514BACKGROUNDTfelt-Hansen P, Pascual J, Ramadan N, Dahlof C, D'Amico D, Diener HC, Hansen JM, Lanteri-Minet M, Loder E, McCrory D, Plancade S, Schwedt T; International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia. 2012 Jan;32(1):6-38. doi: 10.1177/0333102411417901. No abstract available.
PMID: 22384463BACKGROUNDKong J, Gollub R, Huang T, Polich G, Napadow V, Hui K, Vangel M, Rosen B, Kaptchuk TJ. Acupuncture de qi, from qualitative history to quantitative measurement. J Altern Complement Med. 2007 Dec;13(10):1059-70. doi: 10.1089/acm.2007.0524.
PMID: 18166116BACKGROUNDHu J. Acupuncture treatment of migraine in Germany. J Tradit Chin Med. 1998 Jun;18(2):99-101.
PMID: 10437224BACKGROUNDLinde K, Streng A, Jurgens S, Hoppe A, Brinkhaus B, Witt C, Wagenpfeil S, Pfaffenrath V, Hammes MG, Weidenhammer W, Willich SN, Melchart D. Acupuncture for patients with migraine: a randomized controlled trial. JAMA. 2005 May 4;293(17):2118-25. doi: 10.1001/jama.293.17.2118.
PMID: 15870415BACKGROUNDLinde M, Fjell A, Carlsson J, Dahlof C. Role of the needling per se in acupuncture as prophylaxis for menstrually related migraine: a randomized placebo-controlled study. Cephalalgia. 2005 Jan;25(1):41-7. doi: 10.1111/j.1468-2982.2004.00803.x.
PMID: 15606569BACKGROUNDSun LH, Li XH, Li WL, Liu L, Ma HL, Liang YL. [Body acupuncture combined with auricular acupressure for menstrual headache: a randomized controlled clinical trial]. Zhen Ci Yan Jiu. 2015 Feb;40(1):70-4. Chinese.
PMID: 25845225BACKGROUNDWang Y, Xue CC, Helme R, Da Costa C, Zheng Z. Acupuncture for Frequent Migraine: A Randomized, Patient/Assessor Blinded, Controlled Trial with One-Year Follow-Up. Evid Based Complement Alternat Med. 2015;2015:920353. doi: 10.1155/2015/920353. Epub 2015 Apr 28.
PMID: 26060503BACKGROUNDJun EM, Chang S, Kang DH, Kim S. Effects of acupressure on dysmenorrhea and skin temperature changes in college students: a non-randomized controlled trial. Int J Nurs Stud. 2007 Aug;44(6):973-81. doi: 10.1016/j.ijnurstu.2006.03.021. Epub 2006 Jun 16.
PMID: 16782102BACKGROUNDLin JA, Wong CS, Lee MS, Ko SC, Chan SM, Chen JJ, Chen TL. Successful treatment of primary dysmenorrhea by collateral meridian acupressure therapy. J Manipulative Physiol Ther. 2010 Jan;33(1):70-5. doi: 10.1016/j.jmpt.2009.11.003.
PMID: 20114103BACKGROUNDDiener HC, Kronfeld K, Boewing G, Lungenhausen M, Maier C, Molsberger A, Tegenthoff M, Trampisch HJ, Zenz M, Meinert R; GERAC Migraine Study Group. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol. 2006 Apr;5(4):310-6. doi: 10.1016/S1474-4422(06)70382-9.
PMID: 16545747BACKGROUNDYu X, Salmoni A. Comparison of the Prophylactic Effect Between Acupuncture and Acupressure on Menstrual Migraine: Results of a Pilot Study. J Acupunct Meridian Stud. 2018 Oct;11(5):303-314. doi: 10.1016/j.jams.2018.04.003. Epub 2018 Apr 11.
PMID: 29654841DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alan W Salmoni, PhD
Western University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 27, 2015
First Posted
October 30, 2015
Study Start
November 1, 2015
Primary Completion
August 1, 2016
Study Completion
August 1, 2016
Last Updated
October 30, 2015
Record last verified: 2015-10